Safety of guselkumab in patients with plaque psoriasis through 2 years: a pooled analysis from VOYAGE 1 and VOYAGE 2

被引：0
|
作者：
Reich, K. [1 ,2 ]
Papp, K. [3 ]
Armstrong, A. W. [4 ]
Wasfi, Y. [5 ]
Jiang, G. [5 ]
Shen, Y-K. [5 ]
Randazzo, B. [5 ]
Song, M. [5 ]
Kimball, A. B. [6 ]
机构：
[1] Dermatol Hamburg, Hamburg, Germany
[2] SCIderm Res Inst, Hamburg, Germany
[3] K Papp Clin Res & Prob Med Res, Waterloo, ON, Canada
[4] Univ Southern Calif, Los Angeles, CA USA
[5] Janssen Res & Dev LLC, Spring House, PA USA
[6] Beth Israel Deaconess Med Ctr Inc, Boston, MA USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2017年 / 177卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P103
引用
收藏
页码：E297 / E297
页数：1
相关论文
共 50 条
  • [1] Safety of guselkumab in patients with moderate-to-severe psoriasis treated through 100 weeks: a pooled analysis from the randomized VOYAGE 1 and VOYAGE 2 studies
    Reich, K.
    Papp, K. A.
    Armstrong, A. W.
    Wasfi, Y.
    Li, S.
    Shen, Y. K.
    Randazzo, B.
    Song, M.
    Kimball, A. B.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (05) : 1039 - 1049
  • [2] FOUR-YEAR EFFICACY AND SAFETY OF GUSELKUMAB IN PSORIASIS PATIENTS WITH AND WITHOUT PSORIATIC ARTHRITIS: A POOLED ANALYSIS FROM VOYAGE 1 AND VOYAGE 2
    Reich, K.
    Dutz, J.
    Foley, P.
    Thaci, D.
    Vender, R.
    Song, M.
    Miller, M.
    You, Y.
    Li, S.
    Shen, Y. K.
    Armstrong, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1673 - 1673
  • [3] Long-term efficacy and safety of guselkumab in psoriasis patients with and without psoriatic arthritis: A pooled analysis from VOYAGE 1 and VOYAGE 2
    Kimball, A. B.
    Foley, P.
    Thaci, D.
    Vender, R.
    Song, M.
    Li, S.
    Fakharzadeh, S.
    Shen, Y. -K.
    Armstrong, A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB233 - AB233
  • [4] Four-Year Efficacy and Safety of Guselkumab in Psoriasis Patients with and Without Psoriatic Arthritis: A Pooled Analysis from VOYAGE 1 and VOYAGE 2
    Reich, Kristian
    Dutz, Jan
    Foley, Peter
    Thaci, Diamant
    Vender, Ron
    Song, Michael
    Miller, Megan
    Yu, Yin
    Li, Shu
    Shen, Yaung-Kaung
    Armstrong, April W.
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [5] Efficacy of guselkumab in subpopulations of patients with moderate-to-severe plaque psoriasis: a pooled analysis of the phase III VOYAGE 1 and VOYAGE 2 studies
    Gordon, K. B.
    Blauvelt, A.
    Foley, P.
    Song, M.
    Wasfi, Y.
    Randazzo, B.
    Shen, Y. K.
    You, Y.
    Griffiths, C. E. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (01) : 132 - 139
  • [6] Immunogenicity of Guselkumab among psoriasis patients in VOYAGE 1 and VOYAGE 2
    Reich, K.
    Armstrong, A. W.
    Zhu, Y.
    Miller, M.
    You, Y.
    Shen, Y. -K.
    Yang, Y. W.
    Foley, P.
    Griffiths, C. E. M.
    Strober, B.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 42 - 42
  • [7] Guselkumab efficacy and safety through 5 years among psoriasis patients with and without metabolic syndrome at baseline: Results from VOYAGE 1 and VOYAGE 2
    Merola, Joseph F.
    Thaci, Diamant
    Choi, Olivia
    Chan, Daphne
    Yang, Ya-Wen
    Miller, Megan
    You, Yin
    Li, Shu
    Blauvelt, Andrew
    Puig, Luis
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB170 - AB170
  • [8] Absolute Psoriasis Area and Severity Index improvement through 2 years of guselkumab treatment in the VOYAGE 1 trial of patients with plaque psoriasis
    Papp, K.
    Griffiths, C. E. M.
    Kimball, A. B.
    Li, S.
    Shen, Y-K.
    Wasfi, Y.
    Blauvelt, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : E298 - E299
  • [9] Comparable and consistent efficacy responses with up to 3 years of guselkumab treatment in patients with moderate-to-severe plaque psoriasis regardless of prior treatment: Pooled analysis from the VOYAGE 1 and VOYAGE 2 trials
    Gordon, K.
    Guenther, L.
    Pinter, A.
    Choe, Y. -B.
    Song, M.
    Li, S.
    Fakharzadeh, S.
    Shen, Y-K.
    Tsai, T-F.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB185 - AB185
  • [10] Safety of guselkumab in patients with psoriasis with a history of malignancy: 5-year results from the VOYAGE 1 and VOYAGE 2 trials
    Blauvelt, Andrew
    Thaci, Diamant
    Papp, Kim A.
    Ho, Vincent
    Ghoreschi, Kamran
    Kim, Byung Soo
    Miller, Megan
    Shen, Yaung-Kaung
    You, Yin
    Chan, Daphne
    Yu, Jenny
    Yang, Ya-Wen
    Lebwohl, Mark G.
    Gottlieb, Alice B.
    Crowley, Jeffrey
    Foley, Peter
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (01) : 132 - 134
12345